WhiteOak Capital Pharma and Healthcare Fund
WhiteOak Capital
Sectoral / Thematic Highly Differentiated As of 2026-05-31
Holdings
58
Well diversified
Top 10 weight
46%
Concentration
Active share
87%
Highly Differentiated
Equity
-
Asset allocation
Portfolio
7Sectors
16High-conviction bets
58%Top sector wt.
-Cash
Market-cap allocation
Large cap21%
Mid cap18%
Small cap52%
Asset allocation
Asset mix not available.
Top holdings
9.6%
6.8%
4.8%
Laurus Labs LimitedEQUITY
4.4%Clearing Corporation of India LtdCASH_EQUIVALENT
3.9%3.9%
3.3%
3.2%
2.8%
Aurobindo Pharma LimitedEQUITY
2.6%2.5%
2.5%
Corona Remedies LimitedEQUITY
2.3%2.1%
2.1%
Gland Pharma LimitedEQUITY
2.0%1.9%
1.8%
1.8%
Ajanta Pharma LimitedEQUITY
1.7%1.6%
1.6%
182 Days Tbill (MD 06/08/2026)Sovereign
1.5%1.4%
1.4%
1.4%
1.3%
Granules India LimitedEQUITY
1.3%1.3%
1.2%
1.1%
Pfizer LimitedEQUITY
1.1%Innova Captab LimitedEQUITY
1.1%0.9%
0.9%
0.9%
Poly Medicure LimitedEQUITY
0.9%0.8%
Aarti Pharmalabs LimitedEQUITY
0.7%Cipla LimitedEQUITY
0.7%0.7%
0.6%
0.6%
91 Days Tbill (MD 06/08/2026)Sovereign
0.6%91 Days Tbill (MD 13/08/2026)Sovereign
0.6%Abbott India LimitedEQUITY
0.6%Sudeep Pharma LimitedEQUITY
0.5%Zota Health Care LimitedEQUITY
0.5%AI Smart summary
Pros
- Well-diversified across 58 holdings.
Cons
- Small-cap heavy (52%) - higher volatility.
- Concentrated in Pharmaceuticals & Biotechnology - watch sector risk.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Other funds in Sectoral / Thematic.
JioBlackRock Sector Rotation Fund290 holdings · 36% AS
Franklin India Multi-Factor Fund93 holdings · 84% AS
Bandhan Business Cycle Fund93 holdings · 65% AS
WhiteOak Capital Special Opportunities Fund90 holdings · 73% AS
UTI Quant Fund89 holdings · 66% AS
Axis India Manufacturing Fund86 holdings · 73% AS
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
58.0%
28.1%
4.0%
3.0%
1.8%
0.9%